進行・再発大腸がん患者を対象としたPARADIGM探索研究（NCT02394834）のデータの追加解析

基本情報

NCT ID

NCT05030493

ステータス

実施中（募集終了）

試験のフェーズ

-

試験タイプ

観察

目標被験者数

787

治験依頼者名

Takeda

概要

The main aim of the study is to check gene change in tumor tissues with an additional analysis of the data from PARADIGM Exploratory Study, which is conducted for people with advanced/recurrent colorectal cancer. In the PARADIGM Exploratory Study (NCT02394834), the drug being tested in this study is called Panitumumab and the main aim of this study is to check side effect from the study treatment (mFOLFOX6 + bevacizumab versus mFOLFOX6 + panitumumab therapy) and check if the study treatment improves symptoms of advanced/recurrent colorectal cancer.

対象疾患

介入

依頼者（Sponsor）